Amedisys Inc AMED
We take great care to ensure that the data presented and summarized in this overview for AMEDISYS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AMED
View all-
Black Rock Inc. New York, NY3.1MShares$313 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.04MShares$307 Million0.01% of portfolio
-
Pentwater Capital Management LP Naples, FL1.72MShares$173 Million1.13% of portfolio
-
Fil LTD Hamilton, D01.31MShares$133 Million0.12% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ1.1MShares$111 Million5.88% of portfolio
-
State Street Corp Boston, MA1.07MShares$108 Million0.0% of portfolio
-
Norges Bank Oslo, Q8902KShares$91.1 Million0.01% of portfolio
-
Ubs Group Ag879KShares$88.7 Million0.02% of portfolio
-
Tig Advisors, LLC New York, NY857KShares$86.5 Million4.55% of portfolio
-
Qube Research & Technologies LTD London, X0791KShares$79.8 Million0.08% of portfolio
Latest Institutional Activity in AMED
Top Purchases
Top Sells
About AMED
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Insider Transactions at AMED
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 14
2025
|
Jennifer G Griffin Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
341
-100.0%
|
-
|
Aug 14
2025
|
Jennifer G Griffin Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
19,832
-76.98%
|
-
|
Aug 14
2025
|
Vickie L Capps Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,818
-100.0%
|
-
|
Aug 14
2025
|
Teresa L. Kline Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,818
-100.0%
|
-
|
Aug 14
2025
|
Nick Muscato Chief Strategy Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
212
-100.0%
|
-
|
Aug 14
2025
|
Nick Muscato Chief Strategy Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
39,155
-69.53%
|
-
|
Aug 14
2025
|
Nick Muscato Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,468
+50.0%
|
-
|
Aug 14
2025
|
Jeffrey A Rideout Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,335
-100.0%
|
-
|
Aug 14
2025
|
Paul B. K. Kusserow Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
439,745
-100.0%
|
-
|
Aug 14
2025
|
Julie D Klapstein Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,031
-100.0%
|
-
|
Aug 14
2025
|
Molly Joel Coye Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,818
-100.0%
|
-
|
Aug 14
2025
|
Allyson Guidroz Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1
-100.0%
|
-
|
Aug 14
2025
|
Allyson Guidroz Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,472
-54.74%
|
-
|
Aug 14
2025
|
Denise M. Bohnert Chief Compliance Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
214
-100.0%
|
-
|
Aug 14
2025
|
Denise M. Bohnert Chief Compliance Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,395
-82.2%
|
-
|
Aug 14
2025
|
Denise M. Bohnert Chief Compliance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,468
+50.0%
|
-
|
Aug 14
2025
|
Scott G Ginn EVP, CFO & COO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,714
-100.0%
|
-
|
Aug 14
2025
|
Scott G Ginn EVP, CFO & COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
102,128
-78.01%
|
-
|
Aug 14
2025
|
Scott G Ginn EVP, CFO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,399
+50.0%
|
-
|
Aug 14
2025
|
Bruce D Perkins Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,992
-100.0%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 121K shares |
---|---|
Exercise of conversion of derivative security | 120K shares |
Sale (or disposition) back to the issuer | 985K shares |
---|---|
Payment of exercise price or tax liability | 25K shares |
Bona fide gift | 105 shares |
Open market or private sale | 2.42K shares |